After SK Capital buyout, Apotex yanks 6 batches of glaucoma med on sterility concerns fkansteiner Fri, 03/03/2023 – 15:22 More: After SK Capital buyout, Apotex yanks 6 batches of glaucoma med on sterility concerns Source: fierce
read moreAfter AbbVie and Lilly exited UK pricing scheme, Viatris weighs similar move: report zbecker Fri, 03/03/2023 – 11:23 More: After AbbVie and Lilly exited UK pricing scheme, Viatris weighs similar move: report Source: fierce
read moreSanders urges Sanofi, Novo Nordisk to be like Eli Lilly in reducing insulin prices kdunleavy Fri, 03/03/2023 – 10:38 More: Sanders urges Sanofi, Novo Nordisk to be like Eli Lilly in reducing insulin prices Source: fierce
read moreRoche, Exelixis’ Tecentriq-Cabometyx pair fails again—this time in kidney cancer aliu Fri, 03/03/2023 – 09:26 More: Roche, Exelixis' Tecentriq-Cabometyx pair fails again—this time in kidney cancer Source: fierce
read moreCiting J&J’s ‘failure to comply’ with court rules, judge nixes early bid to block Amgen’s Stelara biosim fkansteiner Fri, 03/03/2023 – 09:20 More: Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim
read moreExtensive phase 1 clinical trial evaluates safety of treatment among peritoneal patients More: Sequana Medical announces positive results for DSR 2.0 candidate Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals